Weber Shannon, Lazar Laura, McCord Alan, Romero Charlie, Tan Judy
University of California San Francisco, San Francisco, CA, United States.
PleasePrEPMe, San Francisco, CA, United States.
JMIR Res Protoc. 2020 Sep 22;9(9):e20187. doi: 10.2196/20187.
Pre-exposure prophylaxis is an HIV medication taken by an individual who is HIV-negative to prevent infection before exposure to the virus. Numerous clinical studies in various communities have shown high rates of effectiveness when pre-exposure prophylaxis is taken as prescribed. Since FDA (US Food and Drug Administration) approval of the first product for pre-exposure prophylaxis in 2012, uptake has been lower than the estimated 1.1 million US adults who could benefit from its use, with an estimated 70,394 individuals on pre-exposure prophylaxis in 2017. Of these, only 11% were Black and 13% were Hispanic despite Black and Hispanic individuals comprising two-thirds of individuals who could benefit, highlighting racial and ethnic disparities in pre-exposure prophylaxis uptake. Patient navigators have been shown to be effective in improving the linkage and retention in care outcomes of people living with HIV across the HIV treatment cascade and can be used throughout the pre-exposure prophylaxis care continuum to assist decision making and connect potential users to pre-exposure prophylaxis services.
PleasePrEPMe Chat was designed as a novel online strategy aimed at improving engagement in pre-exposure prophylaxis care services with pre-exposure prophylaxis-eligible populations in California via free HIV-prevention information and health care navigation services.
Visitors connected with navigators via online bilingual (English, Spanish) chat. During the chat, navigators helped locate pre-exposure prophylaxis services through the PleasePrEPMe provider directory, provided links to HIV-prevention resources, and supported uninsured, insured, and undocumented visitors with benefits navigation. Data such as date, time, type of encounter, visitor type, key demographics, discussion topics, insurance, and other relevant information were collected via a chat log and through the HealthEngage chat platform.
From April 2017 to December 2019, PleasePrEPMe completed 2191 online chats. Mean interaction time was 16 minutes, with 68% of chats covering more than one topic. Conversation topics included health care navigation (1104/2191, 50.39%), provider identification (954/2191, 43.54%), pre-exposure prophylaxis information (773/2191, 35.28%), post-exposure prophylaxis information (318/2191, 14.91%), and the California Pre-Exposure Prophylaxis Assistance Program (232/2191, 10.59%). Referrals to pre-exposure prophylaxis- or non pre-exposure prophylaxis-related resources included directory updates, HIV testing and treatment, undetectable=untransmittable, reproductive health, sexually transmitted infections, and other prevention methods. A total of 368 chat visitors completed a voluntary satisfaction scale rating the quality and helpfulness of the service provided, producing a mean rating of 4.7 out of 5.
Online chat is a method for reaching people not already engaged in HIV-prevention services, supporting HIV-prevention decision making, and linking people seeking information online with in-person services. Additional research to evaluate online sexual health information services and understand how social determinants of health influence online engagement is needed to better understand how to reach priority populations not well served by current HIV-prevention services.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/20187.
暴露前预防是未感染艾滋病毒的个体在接触病毒之前服用的一种抗艾滋病毒药物。在不同社区进行的大量临床研究表明,按规定服用暴露前预防药物时有效率很高。自2012年美国食品药品监督管理局(FDA)批准首款用于暴露前预防的产品以来,其使用人数低于估计的110万可能受益的美国成年人,2017年估计有70394人使用暴露前预防药物。其中,只有11%为黑人,13%为西班牙裔,尽管黑人及西班牙裔个体占可能受益个体的三分之二,这凸显了暴露前预防药物使用方面的种族和族裔差异。已证明患者导航员能有效改善艾滋病毒感染者在整个艾滋病毒治疗过程中的护理联系及护理留存情况,并且可在暴露前预防护理全过程中用于协助决策,以及将潜在使用者与暴露前预防服务联系起来。
PleasePrEPMe Chat被设计为一种新颖的在线策略,旨在通过免费的艾滋病毒预防信息和医疗保健导航服务,提高加利福尼亚州符合暴露前预防条件人群对暴露前预防护理服务的参与度。
访问者通过在线双语(英语、西班牙语)聊天与导航员联系。在聊天过程中,导航员通过PleasePrEPMe提供者目录帮助查找暴露前预防服务,提供艾滋病毒预防资源链接,并为未参保、参保及无合法身份的访问者提供福利导航支持。通过聊天记录和HealthEngage聊天平台收集诸如日期、时间、接触类型、访问者类型、关键人口统计学数据、讨论主题、保险及其他相关信息等数据。
2017年4月至2019年12月,PleasePrEPMe完成了2,191次在线聊天。平均互动时间为16分钟,68%的聊天涉及多个主题。对话主题包括医疗保健导航(1,104/2,191,50.39%)、提供者识别(954/2,191,43.54%)、暴露前预防信息(773/2,191,35.28%)、暴露后预防信息(318/2,191,14.91%)以及加利福尼亚暴露前预防援助计划(232/2,191,10.59%)。转介到暴露前预防或非暴露前预防相关资源包括目录更新、艾滋病毒检测与治疗、检测不到=不具传染性、生殖健康、性传播感染及其他预防方法。共有368名聊天访问者完成了一份自愿满意度量表,对所提供服务的质量和帮助程度进行评分,平均评分为4.7(满分5分)。
在线聊天是一种接触尚未参与艾滋病毒预防服务人群、支持艾滋病毒预防决策以及将在线寻求信息的人与面对面服务联系起来的方法。需要开展更多研究来评估在线性健康信息服务,并了解健康的社会决定因素如何影响在线参与度,以便更好地理解如何接触到目前艾滋病毒预防服务未充分覆盖的重点人群。
国际注册报告识别码(IRRID):RR1-10.2196/20187。